GC–MS Analysis of Laser‑Degraded Blue Tattoo Ink
August 21st 2015Laser irradiation of blue tattoo ink can create toxic byproducts - including hydrogen cyanide (HCN) - according to new research published by scientists at the German Federal Institute for Risk Assessment. Pyrolysis gas chromatography–mass spectrometry (Py–GC–MS) was performed on samples of copper phthalocyanine blue to predict the decomposition products resulting from irradiation, as part of a wider on-going project assessing the safety of tattoo inks.
New FDA Guidance on Analytical Methods Provides General Approach, but Few Details
August 18th 2015The United States Food and Drug Administration (FDA) has issued a new guidance document, Analytical Procedures and Method Validation for Drugs and Biologics. The guidance is quite general in nature. Anyone hoping for specific recommendations on topics such as which methods to use will be disappointed. Industry experts say that i really isn’t feasible for the FDA to provide detailed recommendations about analytical methods for biopharmaceuticals, however.
How to Estimate Error in Calibrated Instrument Methods—And Why We Have Stopped Doing It!
August 18th 2015When was the last time you reported your results with an estimate of the error associated with the data? You don’t need to because your method is performing within the levels defined by various agencies and which were confirmed by your validation and your daily QC checks. The person for whom you are producing the data is aware of these tolerances and therefore inherently appreciates the associated precision of the data and can make judgements based on this. Not in the world I work in!
Metabolic Fingerprinting Using GC–MS
August 13th 2015In this new video from LCGC TV, Christian Wachsmuth from the University of Regensburg in Germany compares the performance of different ionization methods for GC–MS in metabolic fingerprinting. He also goes on to talk about how GC–MS could be applied in a clinical setting and what developments are needed for this to happen.
Tips & Tricks GPC/SEC: Strategies to Save Solvent
August 7th 2015Tetrahydrofuran (THF) - a widely used solvent in gel permeation chromatography/size-exclusion chromatography (GPC/SEC) - is set to be classified as carcinogenic as proposed by the Committee for Risk Assessment (RAC). Analytical laboratories therefore need to find ways to reduce THF solvent use and waste, far beyond the demands of green chemistry. This instalment of Tips & Tricks presents different strategies to meet this goal.
Pushing the Boundaries of Proteomics With the New Orbitrap Tribrid Mass Spectrometer
August 6th 2015Dr. Graeme McAlister of Thermo Fisher Scientific will discuss the advances in Orbitrap Tribrid Mass Spectrometry technology with the launch of the new Thermo ScientificTM Orbitrap FusionTM LumosTM TribridTM Mass Spectrometer. Graeme will also touch on how these advances have impacted and will continue to impact proteomics with respect to quantitation, accuracy, throughput, etc.
HRMS in Clinical Research from Targeted Quantitation to Metabolomics
August 3rd 2015In this webinar, we will discuss the use of new, affordable HRMS instruments in quantitative clinical research analyses, demonstrating the sensitivity and selectivity of these instruments for this work. Examples of clinical research quantification work in HR full scan or MS-MS mode will be presented and compared with results from triple-quadrupole-MS. We will also discuss an example of Qual/Quan analysis in a study of the fate of an anti-cancer agent in humans, where over 40 metabolites were identified and quantified. We will also show metabolomics data underscoring the versatility of HRMS instruments.
Living Off the Fat of the Land
August 1st 2015Recently, Nature and Science Citation Index listed the 100 most cited research papers of all time. Two of these are the classic Bligh-Dyer and Folch lipid extraction methods from the late 1950s. This month we will take a look at the lasting impact of these papers and explore the current state of lipid extractions, including lipidomics.